News
ACUS
0.0000
NaN%
--
Weekly Report: what happened at ACUS last week (0908-0912)?
Weekly Report · 09/15/2025 11:01
Weekly Report: what happened at ACUS last week (0901-0905)?
Weekly Report · 09/08/2025 11:02
Weekly Report: what happened at ACUS last week (0825-0829)?
Weekly Report · 09/01/2025 10:58
Weekly Report: what happened at ACUS last week (0818-0822)?
Weekly Report · 08/25/2025 11:08
Weekly Report: what happened at ACUS last week (0811-0815)?
Weekly Report · 08/18/2025 11:01
Weekly Report: what happened at ACUS last week (0804-0808)?
Weekly Report · 08/11/2025 11:07
Weekly Report: what happened at ACUS last week (0728-0801)?
Weekly Report · 08/04/2025 11:09
Weekly Report: what happened at ACUS last week (0721-0725)?
Weekly Report · 07/28/2025 11:11
Weekly Report: what happened at ACUS last week (0714-0718)?
Weekly Report · 07/21/2025 11:01
Weekly Report: what happened at ACUS last week (0707-0711)?
Weekly Report · 07/14/2025 11:10
Weekly Report: what happened at ACUS last week (0630-0704)?
Weekly Report · 07/07/2025 11:02
Weekly Report: what happened at ACUS last week (0623-0627)?
Weekly Report · 06/30/2025 11:08
More
Webull provides a variety of real-time ACUS stock news. You can receive the latest news about Acusphere through multiple platforms. This information may help you make smarter investment decisions.
About ACUS
Acusphere, Inc. is a specialty pharmaceutical company. The Company is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The Company's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The Company has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).